Involvement of circulating fibrocytes in pathophysiology and prognosis of COVID-19 pneumonia

High circulating levels of fibrocytes are correlated to an unfavourable outcome during acute respiratory distress syndrome (ARDS) and idiopathic pulmonary fibrosis. COVID-19 pneumonia shares common histological and inflammatory features with ARDS. We aimed to determine the involvement of circulating fibrocytes during the course of COVID-19 pneumonia, and to assess if fibrocytes could be a prognosis biomarker.

Characterization of the microVAScular dysfunction in COvid-19 ARDS.

Endothelial damage and coagulation activation at the lung microvascular level may play an important role in the physiopathology of the COVID-19 ARDS. The project aims to prospectively investigate both bedside pulmonary physiological markers (mainly alveolar dead-space) and biological markers of coagulopathy and endothelial dysfunction in COVID-19 and non-COVID-19 ARDS patients.

Rights of Marginalized during the Coronavirus Crisis: Hospitality and Commitment

Participatory action research on the residential, educational and food insecurities of exiled people during the health crisis in Rennes.

Coronavirus Diagnostic combined with seasonal Flu Sensing

Worldwide, infections and death from SARS-CoV-2 continue despite lockdown and the use of masks. What started as a temporary sanitary issue, has morphed into a more permanent and long-lasting pan epide

Ecoepidemiology of coronaviruses, from wildlife to the human population, and assessment of the emerging potential

environmental changes. Among RNA viruses, coronaviruses (CoVs) are unique in that, on the one hand, [...] will prove attractive to French experts on coronaviruses, and other experts in wildlife, and enable complex

Multi-scale Eco-evolution of Coronaviruses: from surveillance toward emergence prediction

CK2 inhibitors as chemobiological tools to unravel CK2 role in SARS-COV-2 lifecycle and as potential antivirals with broad-anti-coronavirus activity

rum antiviral activity against other human coronaviruses (HCoV-229E, OC43, NL63 and HKU1).

AiR mOnitoring high-riSk area: Air monitoring of coronaviruses (SARS-CoV2) presence in high-risk area

recently occurring disease caused by the SARS-CoV-2 coronavirus. Its spreading is rapid and hard to control.

Early identification of risk associated with drugs used in COVID-19: analysis of global pharmacovigilance data

Early Identification of Drug Risk in COVID-19: Analysis of Global Pharmacovigilance Data

Endothelial damage and repair in SARS-CoV-2 related vascular injury

Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2